Enantioresolution, stereochemical characterization and biological activity of a chiral large-conductance calcium-activated potassium channel opener.
Roccaldo Sardella, Andrea Carotti, Giuseppe Manfroni, Daniele Tedesco, Alma Martelli, Carlo Bertucci, Violetta Cecchetti, Benedetto Natalini
Index: J. Chromatogr. A. 1363 , 162-8, (2014)
Full Text: HTML
Abstract
A number of large-conductance calcium-activated potassium (BK) channel openers based on the 2-aryl-1,4-benzothiazine scaffold were previously synthesized, and 2-(5-bromo-2-methoxyphenyl)-6-trifluoromethyl-2H-1,4-benzothiazin-3(4H)-one (1) was identified as the most active compound. Since a stereoselective activation of BK channels was demonstrated for arylindolone derivatives, the effect of the absolute configuration at the C-2 position on the vasorelaxing potency of 2-aryl-1,4-benzothiazines is investigated in this article. Compound 1 was initially evaluated as a racemate: subsequently, the "racemic approach" was used to isolate its enantiomers. The excellent enantioresolution obtained using the Sepapak-4 column (CSP 4, cellulose tris(4-chloro-3-metylphenylcarbamate); RS=8.36; α=2.03) allowed to collect highly pure enantiomeric fractions, with enantiomeric excess (e.e.) values higher than 97% and 98% for the first- and second-eluted enantiomer, respectively. Electronic circular dichroism (ECD) studies on the two isolated enantiomers, combined with time-dependent density functional theory (TD-DFT) calculations allowed to characterize the configuration of the enantiomers and determine a (R), (S) elution order. Results from biological assays indicated that the racemate and the isolated enantiomers are endowed with comparable vasorelaxing potency. Copyright © 2014 Elsevier B.V. All rights reserved.
Related Compounds
Related Articles:
2015-05-01
[J. Virol. 89(9) , 4918-31, (2015)]
2015-01-01
[Eur. J. Pharm. Biopharm. 89 , 30-9, (2015)]
2015-01-01
[Nucleic Acids Res. 42(18) , 11433-46, (2014)]
2014-10-01
[Biochim. Biophys. Acta 1838(10) , 2615-24, (2014)]
2014-09-01
[Pharmacol. Biochem. Behav. 124 , 153-9, (2014)]